Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation


      Dietary supplementation with polyphenolic antioxidants to animals was shown to be associated with inhibition of LDL oxidation and macrophage foam cell formation, and attenuation of atherosclerosis development.
      We investigated the effects of pomegranate juice (PJ, which contains potent tannins and anthocyanins) consumption by atherosclerotic patients with carotid artery stenosis (CAS) on the progression of carotid lesions and changes in oxidative stress and blood pressure.
      Ten patients were supplemented with PJ for 1 year and five of them continued for up to 3 years. Blood samples were collected before treatment and during PJ consumption. In the control group that did not consume PJ, common carotid intima-media thickness (IMT) increased by 9% during 1 year, whereas, PJ consumption resulted in a significant IMT reduction, by up to 30%, after 1 year. The patients’ serum paraoxonase 1 (PON 1) activity was increased by 83%, whereas serum LDL basal oxidative state and LDL susceptibility to copper ion-induced oxidation were both significantly reduced, by 90% and 59%, respectively, after 12 months of PJ consumption, compared to values obtained before PJ consumption. Furthermore, serum levels of antibodies against oxidized LDL were decreased by 19%, and in parallel serum total antioxidant status (TAS) was increased by 130% after 1 year of PJ consumption. Systolic blood pressure was reduced after 1 year of PJ consumption by 21% and was not further reduced along 3 years of PJ consumption. For all studied parameters, the maximal effects were observed after 1 year of PJ consumption. Further consumption of PJ, for up to 3 years, had no additional beneficial effects on IMT and serum PON1 activity, whereas serum lipid peroxidation was further reduced by up to 16% after 3 years of PJ consumption.
      The results of the present study thus suggest that PJ consumption by patients with CAS decreases carotid IMT and systolic blood pressure and these effects could be related to the potent antioxidant characteristics of PJ polyphenols.


      To read this article in full you will need to make a payment
      Subscribe to Clinical Nutrition
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Griendling K.K
        • Alexander R.W
        Oxidative stress and cardiovascular diseases.
        Circulation. 1997; 96: 3264-3275
        • Berliner J.A
        • Navab M
        • Fogelman A.M
        • et al.
        Circulation. 1995; 91: 2488-2496
        • Lusis A.J
        Nature. 2000; 407: 233-241
        • Aviram M
        Review of human studies on oxidative damage, and antioxidant protection related to cardiovascular diseases.
        Free Radic Res. 2000; 33: S85-S97
        • Aviram M
        • Fuhrman B
        Flavonoid antioxidants protect LDL from oxidation and attenuate atherosclerosis.
        Curr Opin Lipidol. 2001; 12: 41-48
        • Juliano L
        • Mauriello A
        • Sbarigia E
        • Spagnoli L.G
        • Violi F
        Radiolabeled native low-density lipoprotein injected into patients with carotid stenosis accumulates in macrophages of atherosclerotic plaque.
        Circulation. 2000; 101: 1249-1254
        • Aviram M
        • Rosenblat M
        • Bisgaier C.L
        • Newton R.S
        • Primo-Parmo S.L
        • La Du B.N
        Paraoxonase inhibits high density lipoprotein (HDL) oxidation and preserves its functions.
        J Clin Invest. 1998; 101: 1581-1590
        • Navab M
        • Berliner J.A
        • Watson A.D
        • et al.
        The yin and yang of oxidation in the development of the fatty streak.
        Arterioscler Thromb Vasc Biol. 1996; 17: 831-842
        • Aviram M
        • Hardak E
        • Vaya J
        • et al.
        Human serum paraoxonase (PON1),Q and R selectively decrease lipid peroxides in coronary and carotid atherosclerotic lesions.
        Circulation. 2000; 101: 2510-2517
        • Mackness M.I
        • Arrol S
        • Abott C
        • Durrington P.N
        Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.
        Atherosclerosis. 1993; 104: 129-135
        • Langley P
        Why a pomegranate?.
        Br Med J. 2000; 321: 1153-1154
        • Gil M.I
        • Tomas-Barberan F.A
        • Hess-Pierce B
        • Holcroft D.M
        • Kader A.A
        Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing.
        J Agric Food Chem. 2000; 10: 4581-4589
        • Aviram M
        • Dornfeld L
        • Rosenblat M
        • et al.
        Pomegranate juice consumption reduces oxidative stress, atherogenic modifications of LDL, and platelet aggregation.
        Am J Clin Nutr. 2000; 71: 1062-1076
        • Riley W.A
        • Barnes R.W
        • Applegate W.B
        • et al.
        Reproducibility of noninvasive ultrasonic measurement of carotid atherosclerosis.
        Stroke. 1992; 23: 1062-1068
        • Bots M.L
        • Hoes A.W
        • Koudstaal P.J
        • Hofman A
        • Grobbee D.E
        Common carotid intima-media thickness and the risk of stroke and myocardial infarction.
        Circulation. 1997; 96: 1432-1437
      1. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson Jr SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: cardiovascular health study collaborative research group. New Engl J Med 1999;340:14–22.

        • Rifai N
        • King M.E
        Immuno turbidimetric assays of apolipoprotein A, AI, AII and B in serum.
        Clin Chem. 1986; 32: 957-961
        • Gan K.N
        • Smolen A
        • Eckerson H.W
        • La Du B.N
        Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities.
        Drug Metab Dispos. 1991; 19: 100-106
        • Frei B
        • Stocker R
        • Ames B.N
        Antioxidant defenses and lipid peroxidation in human blood plasma.
        Proc Natl Acad Sci USA. 1988; 85: 9748-9752
        • El-Saadani M
        • Esterbauer N
        • El-Sayed M
        • Goher M
        • Nassar A.Y
        • Jurgens G
        Spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent.
        J Lipid Res. 1989; 30: 627-630
        • Aviram M
        Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients.
        Biochem Med. 1983; 30: 111-118
        • Lowry O.H
        • Rosebrough N.J
        • Farr L
        • Randall R.J
        Protein measurement with the Folin phenol reagent.
        J Biol Chem. 1951; 193: 265-275
        • Esterbauer H
        • Strigel G
        • Puhl H
        • Rothender M
        Continuous monitoring of in vitro oxidation of human low density lipoprotein.
        Free Radic Res Commun. 1989; 6: 67-75
        • Tietze F
        Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione.
        Anal Biochem. 1969; 27: 502-522
      2. Aviram M, Dornfeld L, Kaplan M, et al. Pomegranate juice flavonoids inhibit LDL oxidation and cardiovascular disease: studies in atherosclerotic mice and in humans. Drugs Under Exp Clini Res (Biscience Ediprint Inc.) 2002;28:49–62.

        • Aviram M
        Pomegranate juice as a major source for polyphenolic flavonoids and it is most potent antioxidant against LDL oxidation and atherosclerosis.
        Free Radic Res. 2002; 36: 71-73
        • Cerda B
        • Ceron J.J
        • Tomas-Barberan F.A
        • Espin J.C
        Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic.
        J Agric Food Chem. 2003; 51: 3493-3501
        • Lonn E.M
        • Yusuf S
        • Dzavik V
        • et al.
        Effects of ramipril and vitamin E on atherosclerosis.
        Circulation. 2001; 103: 919-928
        • Salonen J.T
        • Nyyssonen K
        • Salonen R
        • et al.
        Antioxidant supplementation in atherosclerosis prevention (ASAP) study.
        J Intern Med. 2000; 248: 377-386
        • Salonen R.M
        • Nyyssonen K
        • Kaikkonen J
        • et al.
        Antioxidant supplementation in Atherosclerosis Prevention study. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression.
        Circulation. 2003; 107: 947-953
        • Djousse L
        • Folsom A.R
        • Province M.A
        • Hunt S.C
        • Ellison R.C
        Dietary linolenic acid and carotid atherosclerosis.
        Am J Clin Nut. 2003; 77: 819-825
        • Hodis H.N
        • Mack W.J
        • LaBree L
        • et al.
        VEAPS Research Group. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis.
        Circulation. 2002; 106: 1453-1459
        • Rissanen T
        • Voutilainen S
        • Nyyssonen K
        • Salonen R
        • Salonen J.T
        Low plasma lycopen concentration is associated with increased intima-media thickness of the carotid artery wall.
        Arterioscler Thromb Vasc Biol. 2000; 20: 2677-2681
        • Halter J
        • Bokemark L
        • Fagerberg B
        Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year old subjectively clinically healthy men.
        Arterioscler Thromb Vasc Biol. 2001; 21: 101-107
        • Liu M.L
        • Ylitalo K
        • Nuotio I
        • Salonen R
        • Salonen J.T
        • Taskinen M.R
        Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility to oxidation in asymptomatic members of familial combined hyperlipidemia families.
        Stroke. 2002; 33: 1255-1260
        • Patterson C
        • Madamanchi N.R
        • Runge M.S
        The oxidative paradox.
        Circ Res. 2000; 87: 1074-1076
        • Lavy A
        • Brook J.G
        • Dankner G
        • Ben-Amotz, Aviram M
        Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients.
        Metabolism. 1991; 40: 794-799
      3. Fuhrman B, Aviram M. Polyphenols and flavonoids protects LDL against atherogenic modifications. In: Cadenas E, Packer L, editors. Handbook of antioxidants biochemical, nutritional and clinical aspects, vol. 16 2nd ed., NewYork: Marcel Dekker, 2001. p. 303–36.

      4. Aviram M, Fuhrman B. Effects of flavonoids on the oxidation of LDL and atherosclerosis.In: Rice-Evans CA, Packer L. editors. Flavonoids in health and disease, 2nd ed. Revised and Expanded Eds. New York: Marcel Dekker, 2003. p. 165–203.

        • Aviram M
        Dietary antioxidants stimulate the expression of paraoxonases which provides protection against atherosclerosis development.
        Curr Topics Nutraceutical Res. 2003; 3: 161-169
        • Plumb G.W
        • de Pascual-Teresa S
        • Santos-Buelga C
        • Rivas-Gonzalo J.C
        • Williamson G
        Antioxidant properties of gallocathechin and prodelphinidins from pomegranate peel.
        Redox Rep. 2002; 7: 41-46
        • Perez-Vicente A
        • Gil-Izquierdo A
        • Garcia-Viguera C
        In vitro gastrointestinal digestion study of pomegranate juice phenolic compounds, anthocyanins, and vitamin C.
        J Agric Food Chem. 2002; 50: 2308-2312
        • Aviram M
        Does paraoxonase play a role in susceptibility to cardiovascular disease?.
        Mol Med Today. 1999; 5: 381-386
        • McElveen J
        • Mackness M.I
        • Colley C.M
        • Peard T
        • Warner S
        • Walker C.H
        Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction.
        Clin Chem. 1986; 32: 671-673
        • Mackness M.I
        • Harty D
        • Bhatnagar D
        • Winocour P.H
        • Arrol S
        • Ishola M
        • Durrington P.N
        Serum paraoxonase activity in familial hypercholesterolemia and insulin dependent diabetes mellitus.
        Atherosclerosis. 1991; 86: 193-199
        • Fuhrman B
        • Koren L
        • Volkova N
        • Keidar S
        • Hayek T
        • Aviram M
        Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes.
        Atherosclerosis. 2002; 164: 179-185
        • Aviram M
        • Rosenblat M
        • Billecke S
        • et al.
        Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants.
        Free Radic Biol Med. 1999; 26: 892-904
        • Kopprasch S
        • Pietzsch J
        • Kuhlisch E
        • Graessler J
        Lack of association between serum paraoxonase 1 activities and increased oxidized low density lipoprotein levels in impaired glucose tolerance and newly diagnosed diabetes mellitus.
        J Clin Endocrinol Metab. 2003; 88: 1711-1716
        • Aviram M
        • Dornfeld L
        Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure.
        Atherosclerosis. 2001; 158: 195-198
        • Kitiyakara C
        • Wilcox C.S
        Antioxidants for hypertension.
        Curr Opin Nephrol Hypertens. 1998; 7: 531-538
        • Sun P
        • Dwyer K.M
        • Merz C.N
        • et al.
        Blood pressure, LDL cholesterol and intima-media thickness.
        Arterioscler Thromb Vasc Biol. 2000; 20: 2005-2010
        • Kaplan M
        • Hayek T
        • Raz A
        • et al.
        Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis.
        J Nutr. 2001; 131: 2082-2089

      Linked Article